Wednesday, September 16, 2026Latest filing Sep 14, 2026

OGVXX Congressional Stock Trades

JPMORGAN U.S. GOVERNMENT MONEY MARKET FD CAPITAL CL M/M (OGVXX)

Last disclosed trade Jun 23

Every disclosed trade in OGVXX by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

John W. Rose · Sold $OGVXX · Jun 23 · $1.0M–$5.0M

0.64MED
Disclosure speedx 0.250.60
Trade sizex 0.251.00
Cluster activityx 0.150.00
Track recordx 0.350.67

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $OGVXX

Get notified when any member of Congress trades $OGVXX. Free, no card, no spam.

Follow free →
2
Disclosed trades
1
Buys
1
Sells
1
Members trading

The record on $OGVXX

Coldpine has parsed 2 disclosed trades in $OGVXX by 1 member of Congress, drawn from 2 periodic transaction reports dated Jun 3, 2025 through Jun 23, 2025. All of them came from House members, all filed by Republicans.

Of the 2 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 21 days. The longest was 31 days: a $OGVXX purchase by John W. Rose dated Jun 3, 2025, disclosed Jul 4, 2025. How late filing is measured across all of Congress is in the late-filers study.

Members who trade OGVXX

Recent disclosed trades in OGVXX

DateMemberTypeAmount
Jun 23John W. Rose(TN)sell$1.0M–$5.0M
Jun 3John W. Rose(TN)buy$1.0M–$5.0M

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →